Graphite Bio Competitors and Similar CompaniesClear all

Graphite Bio's competitors and similar companies include Asklepios BioPharmaceutical and ProQR Therapeutics.

	Graphite Bio Graphite Bio is a gene-editing company focused on the development of therapies for patients suffering from life-threatening genetic diseases.	Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 2017	Founding Date 2001	Founding Date 2012
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations South San Francisco, US HQ	Locations Chapel Hill, US HQ Roslin, GB	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 27	Employees 5172% increase	Employees 166
Valuation ($)	Valuation ($) 185.2 m	Valuation ($) N/A	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) $19.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €15.9m (FY, 2025)
Cost of goods	Cost of goods $418k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $18.7m (FY, 2025)	Gross profit N/A	Gross profit €16.3m (FY, 2025)
Net income	Net income ($82.1m) (FY, 2025)	Net income N/A	Net income (€42.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 235m	Total funding raised $ 57.8m